Seer’s presence at HUPO 2025 represents one of the most comprehensive demonstrations of its technology to date, with more than a dozen scientific presentations, including two invited talks in the ...

The brain cancer glioblastoma (GBM) is characterized by the presence of cells that can mimic human neurons, even growing axons and making active connections with healthy brain neurons. This cancer ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced ...

Following the advent of massive parallel sequencing, efforts such as The Cancer Genome Atlas (TCGA) use genomics to create mutational landscapes of tumors to create insight into tumor biology, and to ...

The Cancer Prevention and Research Institute of Texas is supporting a Cancer Proteomic and Metabolomic Core Facility that provides consultation, instrumentation, technical support and data analysis ...

“[...] we consider some public molecular resources, including proteomics datasets, that may be leveraged to help identify gene candidates for therapeutic targeting ...

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting." Gene-level ...

Helicobacter pylori is the primary cause of stomach cancer, which is the third leading cause of cancer deaths worldwide. The helical shape of the bacterium is necessary for efficient stomach ...

When a cell divides, a small section of the telomere of each chromosome is worn away. While most cells use the enzyme telomerase to mitigate this loss, about 10–15% of cancers use a different ...

In a recent study published in the journal Nature Biotechnology, researchers introduced deep visual proteomics (DVP), an amalgamation of artificial intelligence (AI) for image analysis and mass ...